Compare
Merit Medical Systems Inc vs Integra Lifesciences Holdings Corp vs Haemonetics Corp vs Teleflex Inc
| Latest fiscal year | Merit Medical Systems Inc MMSI | Integra Lifesciences Holdings Corp IART | Haemonetics Corp HAE | Teleflex Inc TFX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-03-28 | 2025-12-31 |
| Revenue | $1.52B | $1.64B | $1.33B | $1.99B |
| Revenue growth (YoY) | +11.8% | +1.5% | -2.0% | +17.2% |
| Gross margin | 48.7% | 50.9% (computed) | 59.0% | 56.2% |
| Operating margin | 12.2% | -30.2% | 11.7% | 5.9% |
| Net margin | 8.5% | -31.6% | 7.3% | -45.4% |
| Net income | $128.49M | -$516.47M | $97.31M | -$905.64M |
| EPS (Diluted) | $2.13 | -$6.74 | $2.05 | -$20.25 |
| Operating cash flow | $297.37M | $50.38M | $293.22M | $96.68M |
| Free cash flow | $215.66M | -$31.05M | $260.44M | $1.45M |
| Cash & equivalents | $446.40M | $235.05M | $245.44M | $378.56M |
| Total assets | $2.69B | $3.60B | $2.40B | $6.95B |
| Total liabilities | $1.10B | $2.56B | n/a | $3.82B |
| Shareholders' equity | $1.58B | $1.04B | $796.32M | $3.12B |
| Return on year-end equity | 8.1% | -49.5% | 12.2% | -29.0% |
| Shares outstanding | 59.42M | n/a | 45.25M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Merit Medical Systems Inc | Integra Lifesciences Holdings Corp | Haemonetics Corp | Teleflex Inc |
|---|---|---|---|---|
| Latest | $1.52B Ended 2025-12-31 | $1.64B Ended 2025-12-31 | $1.33B Ended 2026-03-28 | $1.99B Ended 2025-12-31 |
| 1 year earlier | $1.36B Ended 2024-12-31 | $1.61B Ended 2024-12-31 | $1.36B Ended 2025-03-29 | $1.70B Ended 2024-12-31 |
| 2 years earlier | $1.26B Ended 2023-12-31 | $1.54B Ended 2023-12-31 | $1.31B Ended 2024-03-30 | $1.71B Ended 2023-12-31 |
| 3 years earlier | $1.15B Ended 2022-12-31 | $1.56B Ended 2022-12-31 | $1.17B Ended 2023-04-01 | $2.79B Ended 2022-12-31 |
| 4 years earlier | $1.07B Ended 2021-12-31 | $1.54B Ended 2021-12-31 | $993.20M Ended 2022-04-02 | $2.81B Ended 2021-12-31 |